| 90Y - PP-F11 | 111In - PP-F11 | 177Lu - PP-F11 | 213Bi - PP-F11 |
---|
N × activity (MBq) | 1 × 111 | 4 × 20 | 8 × 174 | 6 × 47 | 10 × 19 |
N × peptide (nmol) | 0.28 | 4 × 0.05 | 8 × 0.21 | 6 × 0.39 | 10 × 0.47 |
Relative uptake (%) | 70 | 97 | 75 | 62 | 57 |
Tumour mass (mg) | Mean absorbed dose to tumour (Gy) |
1 | 11 | 47 | 45 | 55 |
5 | 19 | 52 | 52 | 57 |
10 | 23 | 54 | 54 | 58 |
50 | 38 | 56 | 58 | 59 |
100 | 46 | 57 | 59 | 59 |
200 | 55 | 59 | 60 | 60 |
300 | 60 | 60 | 60 | 60 |
500 | 68 | 61 | 38 | 60 |
- Multiple (N) injections were considered; only 90Y could attain 60 Gy by a single injection. The relative uptake reduction factor by the higher peptide mass is indicated. The mean absorbed doses are given for tumour spheres varying in mass between 1 and 500 mg according to the mentioned activity and assuming the double-exponential clearance with T1/2 = 2.7 h (60%) and 150 h (40%) without tumour growth. The absorbed dose for 213Bi was not corrected for its relative effectiveness (RBE = 1).